EMR Stock Overview
Engages in the acquisition and exploration of mineral properties in Canada and the United States. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Emergent Metals Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.10 |
52 Week High | CA$0.13 |
52 Week Low | CA$0.03 |
Beta | 0.77 |
11 Month Change | 23.53% |
3 Month Change | 110.00% |
1 Year Change | -22.22% |
33 Year Change | -73.75% |
5 Year Change | -86.00% |
Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
EMR | CA Metals and Mining | CA Market | |
---|---|---|---|
7D | 5.0% | 3.3% | 1.7% |
1Y | -22.2% | 31.8% | 24.0% |
Return vs Industry: EMR underperformed the Canadian Metals and Mining industry which returned 32.2% over the past year.
Return vs Market: EMR underperformed the Canadian Market which returned 23.4% over the past year.
Price Volatility
EMR volatility | |
---|---|
EMR Average Weekly Movement | 21.1% |
Metals and Mining Industry Average Movement | 10.3% |
Market Average Movement | 8.3% |
10% most volatile stocks in CA Market | 17.6% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: EMR's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: EMR's weekly volatility has decreased from 27% to 21% over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | n/a | Dave Watkinson | emergentmetals.com |
Emergent Metals Corp. engages in the acquisition and exploration of mineral properties in Canada and the United States. It explores for gold, silver, molybdenum, copper, base, and other mineral deposits. The company was formerly known as Emgold Mining Corporation and changed its name to Emergent Metals Corp. in March 2022.
Emergent Metals Corp. Fundamentals Summary
EMR fundamental statistics | |
---|---|
Market cap | CA$5.44m |
Earnings (TTM) | -CA$2.13m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.5x
P/E RatioIs EMR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EMR income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$1.53m |
Earnings | -US$1.53m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.029 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 3.4% |
How did EMR perform over the long term?
See historical performance and comparison